| Crystal structure of a Fab fragment with its ligand peptide | |
Heteromer
| 126-137 | 91.67 | 6×SO4; |
|
| Crystal structure of human cytosolic NADP(+)-dependent isocitrate dehydrogenase in complex with NAD… | | homo-2-mer | 1-414 | 100 | 2×CA; 2×NAP; 2×ICT; |
|
| Crystal structure of human cytosolic NADP(+)-dependent isocitrate dehydrogenase in complex NADP | | homo-2-mer | 1-414 | 100 | 2×NAP; |
|
| Crystal structure of IDH1 R132H in complex with HMS101 | | homo-2-mer | 1-414 | 99.75 | 2×HJQ; |
|
| Crystal structure of homodimeric R132H mutant of human cytosolic NADP(+)-dependent isocitrate dehyd… | | homo-2-mer | 1-414 | 99.75 | 2×NAP; |
|
| Crystal Structure of Human IDH1 R132Q in complex with NADPH and Alpha-Ketoglutarate | | homo-2-mer | 1-413 | 99.76 | 1×AKG; 1×NDP; 5×GOL; 10×SCN; 2×CL; 2×CA; 1×EE1; |
|
| Crystal Structure of Ivosidenib-resistant IDH1 variant R132C S280F in complex with NADPH and Ca2+/2… | | homo-2-mer | 2-414 | 99.52 | 2×AKG; 2×GOL; 2×NDP; 2×CA; 2×CL; |
|
| Crystal Structure of Human IDH1 R132Q in complex with NADPH and Alpha-Ketoglutarate | | homo-2-mer | 1-413 | 99.76 | 1×EE1; 2×NO3; 2×CA; 1×NDP; 1×AKG; |
|
| Crystal Structure of Human IDH1 R132Q in complex with NADPH and Isocitrate | | homo-2-mer | 1-413 | 99.76 | 2×NAP; 2×IOD; 2×CA; 1×GOL; |
|
| CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC ISOCITRATE DEHYDROGENASE (IDH1) R132H MUTANT IN COMPLEX WITH N… | | homo-2-mer | 2-414 | 99.76 | 2×NDP; 1×QWM; |
|
| Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd1 | | homo-2-mer | 3-414 | 100 | 2×CA; 2×ICT; 2×DWP; |
|
| IDH1 R132H in complex with cpd 1 | | homo-2-mer | 3-414 | 99.76 | 1×VVS; 2×NAP; 1×GOL; |
|
| Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd15 | | homo-2-mer | 3-414 | 100 | 2×CA; 2×ICT; 2×DWS; |
|
| Novel Modes of Inhibition of Wild-Type IDH1: Non-equivalent Allosteric Inhibition with Cmpd3 | | homo-2-mer | 3-414 | 100 | 2×NAP; 2×DWM; |
|
| Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd13 | | homo-2-mer | 3-414 | 100 | 2×ICT; 2×DWG; 2×CA; |
|
| Crystal structure of the R132H mutant of IDH1 bound to AG-120 | | homo-2-mer | 3-414 | 99.75 | 2×NAP; 1×IV3; |
|
| Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate | | homo-2-mer | 3-414 | 99.76 | 2×NAP; 2×CA; 1×EDO; 2×AKG; |
|
| Crystal Structure of Human Cytosolic Isocitrate Dehydrogenase (IDH1) R132H Mutant in Complex with N… | | homo-2-mer | 3-414 | 99.76 | 2×NDP; 1×SO4; 1×33O; 4×PEG; 1×ACT; 1×MLA; 1×9UO; 1×MLT; |
|
| Crystal structure of IDH1 R132H mutant in complex with FT-2102 | | homo-2-mer | 3-414 | 99.76 | 2×NAP; 2×CL; 2×PWV; 1×FLC; |
|
| Crystal Structure of Human IDH1 R132Q in complex with NADPH | | homo-2-mer | 3-414 | 99.75 | 5×GOL; 2×NDP; 1×CIT; |
|
| Crystal Structure of Human IDH1 R132Q in Complex with NADPH-TCEP Adduct | | homo-2-mer | 1-412 | 99.76 | 2×A1AAX; 6×GOL; 2×CL; 2×CA; 1×SCN; |
|
| Novel Modes of Inhibition of Wild-Type IDH1:Direct Covalent Modification of His315 with Cmpd11 | | homo-2-mer | 3-414 | 100 | 2×MG; 2×ICT; 1×DWJ; 1×NAP; |
|
| Novel Binding Modes of Inhibition of Wild-Type IDH1: Allosteric Inhibition with Cmpd2 | | homo-2-mer | 3-414 | 100 | 1×LMR; 2×MG; 1×K32; |
|
| IDH1 R132H mutant in complex with IDH889 | | homo-2-mer | 3-414 | 99.75 | 2×FLC; 2×7J2; 2×NDP; |
|
| Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate | | homo-2-mer | 3-414 | 99.76 | 2×CA; 2×NAP; 2×AKG; 1×EDO; |
|
| Crystal structure of human IDH1 in complex with GSK321A | | homo-2-mer | 3-414 | 99.75 | 2×NAP; 2×59D; |
|
| Crystal structure of the R132H mutant of IDH1 bound to compound 1 | | homo-2-mer | 3-414 | 99.75 | 2×NAP; 2×ZT3; |
|
| Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate | | homo-2-mer | 3-414 | 99.76 | 2×CA; 2×NAP; 2×AKG; |
|
| IDH1 R132H mutant in complex with IDH305 | | homo-2-mer | 3-414 | 99.75 | 2×NDP; 3×C81; 2×FLC; |
|
| Crystal Structure of IDH1 variant R132C S280F in complex with NADPH, Ca2+ and 3-butyl-2-oxoglutarate | | homo-2-mer | 3-414 | 99.52 | 3×GOL; 2×NDP; 2×QDC; 2×QD8; 2×CA; |
|
| Crystal Structure of Human IDH1 R132Q in complex with NADPH | | homo-2-mer | 3-414 | 99.75 | 2×GOL; 2×NDP; 2×SO4; |
|
| Crystal Structure of Ivosidenib-resistant IDH1 variant R132C S280F in complex with NADPH and inhibi… | | homo-2-mer | 2-413 | 99.51 | 2×7SU; 3×CIT; 2×GOL; 2×NDP; |
|
| Crystal structure of IDH1 R132H mutant in complex with compound 32 | | homo-2-mer | 3-414 | 99.76 | 2×LJV; 2×NAP; 2×GOL; |
|
| Human isocitrate dehydrogenase 1 bound with isocitrate | | homo-2-mer | 1-412 | 100 | 2×MG; 2×ICT; 2×K; |
|
| Crystal structure of Iso-citrate Dehydrogenase R132H in complex with a novel inhibitor (compound 13… | | homo-2-mer | 3-414 | 98.53 | 2×NDP; 2×6N3; |
|
| Crystal Structure of human IDH1 mutant (R132H) in complex with NADP+ and an Inhibitor related to BA… | | homo-2-mer | 3-414 | 99.75 | 2×NAP; 1×EDO; 1×6VN; |
|
| Crystal structure of IDH1 R132H mutant in complex with compound 24 | | homo-2-mer | 3-414 | 99.76 | 2×LJY; 2×NAP; 1×BME; |
|
| Crystal Structure of Human IDH1 R132H Mutant in Complex with NADPH and Compound IHMT-IDH1-053 | | homo-2-mer | 1-412 | 99.75 | 2×R1R; 2×NDP; 5×GOL; 5×PEG; |
|
| Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate | | homo-2-mer | 3-414 | 99.76 | 2×AKG; 2×CA; 2×NAP; |
|
| Crystal Structures of IDH1 R132H in complex with AG-881 | | homo-2-mer | 3-414 | 99.76 | 2×NDP; 2×MG; 1×9UO; |
|
| Crystal structure of Iso-citrate Dehydrogenase 1 [IDH1 (R132H)] in complex with a novel inhibitor (… | | homo-2-mer | 3-414 | 98.4 | 2×NDP; 2×6MX; |
|
| Crystal structure of heterodimeric R132H mutant of human cytosolic NADP(+)-dependent isocitrate deh… | | homo-2-mer | 3-414 | 99.75 | 2×NAP; 2×ICT; |
|
| Crystal structure of wild type IDH1 bound to compound 1 | | homo-2-mer | 3-414 | 100.0 | 2×ZT3; |
|
| IDH1 R132H in complex with cpd 1 | | homo-2-mer | 3-413 | 99.74 | 4×SO4; 1×GOL; 2×NAP; |
|
| Crystal structure of human cytosolic NADP(+)-dependent isocitrate dehydrogenase R132H mutant in com… | | homo-2-mer | 4-414 | 99.75 | 2×NDP; 2×AKG; 2×CA; 2×NA; 2×GOL; |
|
| Human IDH1 R132C mutant complexed with compound A. | | homo-2-mer | 3-413 | 99.75 | 2×AOU; 2×NDP; 3×CIT; 7×GOL; |
|
| IDH1 R132H in complex with IDH125 | | homo-2-mer | 4-414 | 99.75 | 2×NDP; 2×70P; 2×FLC; |
|
| IDH1 R132H in complex with IDH146 | | homo-2-mer | 3-413 | 99.74 | 2×NDP; 2×70Q; 4×SO4; 2×EDO; 2×DMS; |
|
| Crystal structure of homodimeric R132H mutant of human cytosolic NADP(+)-dependent isocitrate dehyd… | | homo-2-mer | 3-413 | 99.75 | 2×NAP; 2×ICT; |
|
| Crystal structure of a metabolic reductase with (E)-5-((1-methyl-5-oxo-2-thioxoimidazolidin-4-ylide… | | homo-2-mer | 3-413 | 99.74 | 2×NDP; 1×42V; |
|
| Crystal structure of a metabolic reductase with (E)-1-benzyl-5-((1-methyl-5-oxo-2-thioxoimidazolidi… | | homo-2-mer | 3-413 | 99.74 | 2×42W; 2×NAP; |
|
| Cryo-EM structure of isocitrate dehydrogenase (IDH1) | | homo-2-mer | 3-413 | 99.75 | 2×NDP; |
|
| Cryo-EM structure of isocitrate dehydrogenase (IDH1) in inhibitor-bound state | | homo-2-mer | 3-413 | 99.75 | 2×NDP; |
|
| Structure of HsICDH1:Mg(II):ICT:NADPH(50%) complex reveals structural basis for observation of half… | | homo-2-mer | 4-412 | 100 | 2×ICT; 2×MG; 1×NDP; 5×FMT; |
|
| Human isocitrate dehydrogenase 1 bound with NADP | | homo-2-mer | 3-411 | 100 | 2×NAP; 2×MG; |
|
| Crystal structure of a metabolic reductase with 6-benzyl-1-hydroxy-4-methylpyridin-2(1H)-one | | homo-2-mer | 4-411 | 99.73 | 2×NDP; 2×SO4; 1×1BZ; |
|
| Crystal structure of a metabolic reductase with 1-hydroxy-6-(4-hydroxybenzyl)-4-methylpyridin-2(1H)… | | homo-2-mer | 4-411 | 99.73 | 2×NDP; 4×SO4; 1×1BX; |
|